Dynamic Light Scattering (DLS) Particle Size Analyzer
Pharma Industry Review
by Pharmaceutical Industry Editor
1w ago
The cutting-edge Dynamic Light Scattering (DLS) Particle Size Analyzer SpectroLight 600/610 is a powerful benchtop device that enables precise particle size determination in plates with unmatched small sample volumes. Developed by leading DLS technology experts Xtal Concepts, the SpectroLight 600/610 provides highly accurate and advanced insights into particle behaviour and characteristics, revolutionising scientific and pharmaceutical research methodologies. Dynamic Light Scattering (DLS) Particle Size Analyzer The SpectroLight 600/610 is a groundbreaking fully automated Dynamic Light Sc ..read more
Visit website
AstraZeneca Expands Rare Disease Pipeline with Amolyt Pharma Acquisition
Pharma Industry Review
by Pharmaceutical Industry Editor
1w ago
AstraZeneca has announced it is set to acquire Amolyt Pharma, a French clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases, for a total consideration of up to $1.05 billion. The purchase will expand AstraZeneca’s rare disease pipeline beyond complement inhibition, building on the company’s success in bone metabolism and opportunity in rare endocrinology. The proposed acquisition stands to fortify the Rare Disease late-stage pipeline of Alexion and AstraZeneca, while also expanding its bone metabolism franchise through the inclusion of enebopa ..read more
Visit website
Encouraging Outcomes for Novel Therapy Targeting Drug-resistant Tuberculosis
Pharma Industry Review
by Pharmaceutical Industry Editor
2w ago
Researchers have made a significant leap forward in the fight against drug-resistant tuberculosis (TB), according to a recent study published in the Journal of Medicinal Chemistry, Volume 67, Issue 4. The article highlights the discovery of a series of azetidine derivatives, referred to as BGAz compounds, that exhibit potent bactericidal activity against both drug-sensitive Mycobacterium tuberculosis and multidrug-resistant TB strains. The Present Status of Tuberculosis Tuberculosis continues to be a global health concern. According to the World Health Organisation, over 10 ..read more
Visit website
Cutting-Edge Laser Microdissection Advancements – Video
Pharma Industry Review
by Pharmaceutical Industry Editor
2w ago
MMI has introduced the next generation of laser microdissection systems – the CellCut. Breakthrough Advancements for Clean and Precise Dissection This cutting-edge laser microdissection technology brings breakthrough advancements for clean and precise dissection of any sample type, including live or fixed cells, cell clusters, single cells, or subcellular components. The Future of Single Cell Isolation The cutting-edge technology effectively eliminates the risk of contamination through contact-free cutting of single cells or tissue. Unlike systems reliant on gravity for sample collec ..read more
Visit website
Choosing the Right Well Plate Format for Your Research
Pharma Industry Review
by Pharmaceutical Industry Editor
3w ago
Choosing the most appropriate well system format, whether it’s a transwell, non-transwell, or individual transwell, can drastically affect the outcome of experiments in preclinical research, and drug discovery. It is critical to select the appropriate well plate when working with permeability, toxicity, drug screening, or other assays. Each format offers distinct advantages and functionalities that directly impact the reliability and relevance of research results. In this article, we will explore the various formats of ReadyCell’s products, their common applications, and how they can be adapte ..read more
Visit website
Placing Regulatory Compliance at the Core of Pharmaceutical Supply Chains
Pharma Industry Review
by Pharmaceutical Industry Editor
3w ago
    Optimising Efficiency with Data Loggers In the fast-paced and highly regulated landscape of the pharmaceutical industry, ensuring compliance with stringent regulatory standards is not just a legal requirement but a fundamental aspect of maintaining public trust and safety. The integration of advanced technologies, such as data loggers, into pharmaceutical supply chains has become a crucial strategy for companies to navigate the complex web of regulations while concurrently enhancing operational efficiency. The AiroSensor wireless data loggers, manufactured by the market ..read more
Visit website
Rapid Plasma Protein Binding Assay
Pharma Industry Review
by Pharmaceutical Industry Editor
1M ago
The unique rapid plasma protein binding assay for sticky and tightly bound compounds can be used with plasma from any species. The ready-to-use 96-well Plasma Protein Binding Assay revolutionises the assessment of plasma protein binding with its unparalleled efficiency. Unlike traditional methods, these assay kits utilise matrix-free technology, with binding proteins immobilized on beads, offering a multitude of advantages. Plasma Protein Binding Assay The Plasma Protein Binding Assay is a versatile and highly accurate, ready-to-use, high-sensitivity plasma protein binding kit that requires o ..read more
Visit website
Fast High-Throughput Assay for Brain Tissue Binding
Pharma Industry Review
by Pharmaceutical Industry Editor
1M ago
The fast high-throughput Assay for Brain Tissue Binding developed by Sovicell and GSK is ready to use and requires only 20 minutes for brain tissue binding and brain disposition. Assay for Brain Tissue Binding The TRANSIL Brain Absorption kit estimates the binding of drugs to brain tissue and predicts the disposition of drugs into the brain. Developed in cooperation with GlaxoSmithKline (GSK), it measures the affinity of drugs to reconstituted porcine brain membranes. The brain membrane affinity is used to estimate the brain tissue binding and to predict the brain-to-plasma distribution via a ..read more
Visit website
FDA Greenlights Iovance’s AMTAGVI™ as First T-cell Therapy for a Solid Tumor Cancer
Pharma Industry Review
by Pharmaceutical Industry Editor
1M ago
Iovance Biotherapeutics, Inc., a leading biotechnology firm specialising in pioneering, developing, and delivering advanced polyclonal tumor infiltrating lymphocyte (TIL) cell therapies for cancer patients, announced a significant milestone. The U.S. Food and Drug Administration (FDA) has approved AMTAGVI (lifileucel) suspension for intravenous infusion as the first T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after anti-PD-1 and targeted therapy. AMTAGVI (lifileucel) product packaging (Image Credits: Iovance Biotherapeutics, Inc.) This groundbreakin ..read more
Visit website
Nucleosides, Nucleotides & Nucleic Acids Toolbox – Part 2 – Free E-Book – Biosynth
Pharma Industry Review
by Pharmaceutical Industry Editor
2M ago
Nucleosides, Nucleotides & Nucleic Acids Toolbox – Part 2 – E-Book Now Available! A Biosynth .pdf E-Book Part 2 – Nucleic Acids: The Basis of Genes, Biological Significance, Chemistry, Analysis, Applications Biosynth is excited to announce the launch of the second part of its E-Book, “Nucleosides, Nucleotides, and Nucleic Acids Toolbox”. Following on from Nucleosides, Nucleotides and their Analogs Toolbox Part 1, the second part of the E-Book focuses on the discovery of the oligomers, including DNA and RNA, Biosynth’s molecules of inheritance. Together with the newly launched Part 2, this ..read more
Visit website

Follow Pharma Industry Review on FeedSpot

Continue with Google
Continue with Apple
OR